Oluwaseun Akeju1, M Brandon Westover, Kara J Pavone, Aaron L Sampson, Katharine E Hartnack, Emery N Brown, Patrick L Purdon. 1. From the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts (O.A., K.J.P., A.L.S., K.E.H., E.N.B., P.L.P.); Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts (M.B.W.); Harvard Medical School, Boston, Massachusetts (O.A., E.N.B., P.L.P.); Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, Massachusetts (M.B.W., E.N.B., P.L.P.); Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts (E.N.B.); and Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (E.N.B.).
Abstract
BACKGROUND: The neural mechanisms of anesthetic vapors have not been studied in depth. However, modeling and experimental studies on the intravenous anesthetic propofol indicate that potentiation of γ-aminobutyric acid receptors leads to a state of thalamocortical synchrony, observed as coherent frontal alpha oscillations, associated with unconsciousness. Sevoflurane, an ether derivative, also potentiates γ-aminobutyric acid receptors. However, in humans, sevoflurane-induced coherent frontal alpha oscillations have not been well detailed. METHODS: To study the electroencephalogram dynamics induced by sevoflurane, the authors identified age- and sex-matched patients in which sevoflurane (n = 30) or propofol (n = 30) was used as the sole agent for maintenance of general anesthesia during routine surgery. The authors compared the electroencephalogram signatures of sevoflurane with that of propofol using time-varying spectral and coherence methods. RESULTS: Sevoflurane general anesthesia is characterized by alpha oscillations with maximum power and coherence at approximately 10 Hz, (mean ± SD; peak power, 4.3 ± 3.5 dB; peak coherence, 0.73 ± 0.1). These alpha oscillations are similar to those observed during propofol general anesthesia, which also has maximum power and coherence at approximately 10 Hz (peak power, 2.1 ± 4.3 dB; peak coherence, 0.71 ± 0.1). However, sevoflurane also exhibited a distinct theta coherence signature (peak frequency, 4.9 ± 0.6 Hz; peak coherence, 0.58 ± 0.1). Slow oscillations were observed in both cases, with no significant difference in power or coherence. CONCLUSIONS: The study results indicate that sevoflurane, like propofol, induces coherent frontal alpha oscillations and slow oscillations in humans to sustain the anesthesia-induced unconscious state. These results suggest a shared molecular and systems-level mechanism for the unconscious state induced by these drugs.
BACKGROUND: The neural mechanisms of anesthetic vapors have not been studied in depth. However, modeling and experimental studies on the intravenous anesthetic propofol indicate that potentiation of γ-aminobutyric acid receptors leads to a state of thalamocortical synchrony, observed as coherent frontal alpha oscillations, associated with unconsciousness. Sevoflurane, an ether derivative, also potentiates γ-aminobutyric acid receptors. However, in humans, sevoflurane-induced coherent frontal alpha oscillations have not been well detailed. METHODS: To study the electroencephalogram dynamics induced by sevoflurane, the authors identified age- and sex-matched patients in which sevoflurane (n = 30) or propofol (n = 30) was used as the sole agent for maintenance of general anesthesia during routine surgery. The authors compared the electroencephalogram signatures of sevoflurane with that of propofol using time-varying spectral and coherence methods. RESULTS:Sevoflurane general anesthesia is characterized by alpha oscillations with maximum power and coherence at approximately 10 Hz, (mean ± SD; peak power, 4.3 ± 3.5 dB; peak coherence, 0.73 ± 0.1). These alpha oscillations are similar to those observed during propofol general anesthesia, which also has maximum power and coherence at approximately 10 Hz (peak power, 2.1 ± 4.3 dB; peak coherence, 0.71 ± 0.1). However, sevoflurane also exhibited a distinct theta coherence signature (peak frequency, 4.9 ± 0.6 Hz; peak coherence, 0.58 ± 0.1). Slow oscillations were observed in both cases, with no significant difference in power or coherence. CONCLUSIONS: The study results indicate that sevoflurane, like propofol, induces coherent frontal alpha oscillations and slow oscillations in humans to sustain the anesthesia-induced unconscious state. These results suggest a shared molecular and systems-level mechanism for the unconscious state induced by these drugs.
Authors: Shinung Ching; Aylin Cimenser; Patrick L Purdon; Emery N Brown; Nancy J Kopell Journal: Proc Natl Acad Sci U S A Date: 2010-12-13 Impact factor: 11.205
Authors: Rodolfo Llinás; Francisco J Urbano; Elena Leznik; Rey R Ramírez; Hein J F van Marle Journal: Trends Neurosci Date: 2005-06 Impact factor: 13.837
Authors: Zhe Chen; Patrick L Purdon; Grace Harrell; Eric T Pierce; John Walsh; Emery N Brown; Riccardo Barbieri Journal: Ann Biomed Eng Date: 2010-10-13 Impact factor: 3.934
Authors: Patrick L Purdon; Eric T Pierce; Eran A Mukamel; Michael J Prerau; John L Walsh; Kin Foon K Wong; Andres F Salazar-Gomez; Priscilla G Harrell; Aaron L Sampson; Aylin Cimenser; ShiNung Ching; Nancy J Kopell; Casie Tavares-Stoeckel; Kathleen Habeeb; Rebecca Merhar; Emery N Brown Journal: Proc Natl Acad Sci U S A Date: 2013-03-04 Impact factor: 11.205
Authors: Thomas Thiery; Tarek Lajnef; Etienne Combrisson; Arthur Dehgan; Pierre Rainville; George A Mashour; Stefanie Blain-Moraes; Karim Jerbi Journal: Neuroimage Date: 2018-06-07 Impact factor: 6.556
Authors: O Akeju; K J Pavone; J A Thum; P G Firth; M B Westover; M Puglia; E S Shank; E N Brown; P L Purdon Journal: Br J Anaesth Date: 2015-07 Impact factor: 9.166
Authors: P L Purdon; K J Pavone; O Akeju; A C Smith; A L Sampson; J Lee; D W Zhou; K Solt; E N Brown Journal: Br J Anaesth Date: 2015-07 Impact factor: 9.166
Authors: George S Plummer; Reine Ibala; Eunice Hahm; Jingzhi An; Jacob Gitlin; Hao Deng; Kenneth T Shelton; Ken Solt; Jason Z Qu; Oluwaseun Akeju Journal: Clin Neurophysiol Date: 2018-11-16 Impact factor: 3.708
Authors: Phillip E Vlisides; Duan Li; Mackenzie Zierau; Andrew P Lapointe; Ka I Ip; Amy M McKinney; George A Mashour Journal: Anesthesiology Date: 2019-06 Impact factor: 7.892